Save the date & Join the @US_FDA’s Patient Engagement Advisory Committee on Nov 15th to discuss patient-generated health data from sources like social media, activity trackers, and patient-driven registries. Learn more: https://t.co/yTd2SS6IsO #DigitalHealth#PEAC2018
Special populations (i.e. children, seniors, the cognitively impaired) require unique considerations as we develop and implement COAs-Privileged to guide internal and external experts as we continue to enhance medical products for everyone @FDA_Drug_Info
https://t.co/DDADKgS9uw
Patient-focused medical product development is a priority for the FDA- Looking forward to moderating discussions on what’s important in the selection and use of clinical outcomes assessments (COA) for people living with health concerns @FDA_Drug_Info https://t.co/N7opVVeSxz
Innovation in #Pediatrics means innovation for everyone. Honored to engage with regulatory professionals across the world helping ensure safe and effective medical products save and improve lives #RAPS2018#devices4kids#anddevices
Wonderful to experience so much expertise, talent and passion aligning to enhance medical device innovation and healthcare for children #devices4kids#Innovate4Kids#anddevices
We hope this extra time will allow stakeholders to continue to provide input on the ideas shared during the two-day Pediatric Device Development public meeting held last month. #devices4kids https://t.co/uUqvHRaWeX
The public comment period gives the @FDAcdrhIndustry, and everyone that is in attendance at the public meeting, the chance to hear new voices and their perspectives #devices4kids
Today, the FDA hosted the 1st day of the public meeting, Pediatric Medical Device Development. You can register on-site, so we hope more join us tomorrow! #Devices4kids https://t.co/qavfnQz7Y3